IP Verse

Methods And Formulations Which Allow The Modulation Of Immune Responses Related To The Administration Of A Biopharmaceutical Drug - EP3021833

PATENT ANALYSIS

Patent Details

Grant Date
Mar 30, 2022
Company
HEXAL AKTIENGESELLSCHAFT
Oppositions

MURPHY, COLM DAMIEN

More patents of Hexal Aktiengesellschaft

EP3021833

Want to monitor this patent?

Feel free to send us a message here and we will get back to you